INSM 8-K 2026-10-05
INSMED Inc (INSM) 8-K dated 2026-10-05 — accession 0001140361-26-038529.
INSMED Inc (INSM) is a biotechnology company listed on US.
INSMED Inc filed a 8-K on 2026-10-05. Accession 0001140361-26-038529.
This 8-K covers: Director/officer change (Item 5.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported INSM revenue for 2025-12-31 was $606.4M. Net income was -$1.28B. Revenue was up 66.7% from 2024-12-31 to 2025-12-31. INSM currently screens at market cap $20.42B.
Not investment advice. The INSM SEC hub lists recent forms. The stock page is the research view.